Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1989 May;44(5):391–395. doi: 10.1136/thx.44.5.391

Anginal chest pain in sarcoidosis.

J L Wait 1, A Movahed 1
PMCID: PMC461840  PMID: 2763237

Abstract

Of 43 consecutive black patients (42 male) with sarcoidosis, 12 (28%) complained of chest pain that met the clinical criteria for typical (four patients) or atypical (eight patients) angina pectoris. These patients underwent cardiopulmonary assessment, which included exercise and redistribution thallium-201 scans and, if indicated, coronary angiography. Nine control patients with sarcoidosis matched for age and duration of disease, but without chest pain, were also studied by thallium-201 scintigraphy. Six of the 12 patients with chest pain had thallium scans indicative of myocardial ischaemia, but all had normal coronary angiograms; no patient from the control group had evidence of ischaemia on the thallium scan. Four additional patients with chest pain and one from the control group had other (non-specific) abnormalities on the thallium scan, so that scans were abnormal in 10 of the 12 patients with sarcoidosis who had chest pain. Most patients with anginal chest pain reported partial or complete relief of symptoms with nitrates. Anginal chest pain appears to be common in black male patients with sarcoidosis, is associated with abnormal myocardial perfusion scans, and may result from myocardial sarcoidosis.

Full text

PDF
391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boucher C. A., Zir L. M., Beller G. A., Okada R. D., McKusick K. A., Strauss H. W., Pohost G. M. Increased lung uptake of thallium-201 during exercise myocardial imaging: clinical, hemodynamic and angiographic implications in patients with coronary artery disease. Am J Cardiol. 1980 Aug;46(2):189–196. doi: 10.1016/0002-9149(80)90057-0. [DOI] [PubMed] [Google Scholar]
  2. Bulkley B. H., Rouleau J. R., Whitaker J. Q., Strauss H. W., Pitt B. The use of 201thallium for myocardial perfusion imaging in sarcoid heart disease. Chest. 1977 Jul;72(1):27–32. doi: 10.1378/chest.72.1.27. [DOI] [PubMed] [Google Scholar]
  3. Epstein S. E. Implications of probability analysis on the strategy used for noninvasive detection of coronary artery disease. Role of single or combined use of exercise electrocardiographic testing, radionuclide cineangiography and myocardial perfusion imaging. Am J Cardiol. 1980 Sep;46(3):491–499. doi: 10.1016/0002-9149(80)90020-x. [DOI] [PubMed] [Google Scholar]
  4. Fleming H. A. Sarcoid heart disease: a review and an appeal. Thorax. 1980 Sep;35(9):641–643. doi: 10.1136/thx.35.9.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Follansbee W. P., Curtiss E. I., Medsger T. A., Jr, Steen V. D., Uretsky B. F., Owens G. R., Rodnan G. P. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med. 1984 Jan 19;310(3):142–148. doi: 10.1056/NEJM198401193100302. [DOI] [PubMed] [Google Scholar]
  6. Haywood L. J., Sharma O. P., Siegel M. E., Siegel R. J., Gottlieb S. L., Caldwell J., Siemsen J. K. Detection of myocardial sarcoidosis by thallium 201 imaging. J Natl Med Assoc. 1982 Oct;74(10):959–964. [PMC free article] [PubMed] [Google Scholar]
  7. Kinney E. L., Jackson G. L., Reeves W. C., Zelis R. Thallium-scan myocardial defects and echocardiographic abnormalities in patients with sarcoidosis without clinical cardiac dysfunction. An analysis of 44 patients. Am J Med. 1980 Apr;68(4):497–503. doi: 10.1016/0002-9343(80)90292-2. [DOI] [PubMed] [Google Scholar]
  8. Knudson R. J., Lebowitz M. D., Holberg C. J., Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983 Jun;127(6):725–734. doi: 10.1164/arrd.1983.127.6.725. [DOI] [PubMed] [Google Scholar]
  9. Makler P. T., Lavine S. J., Denenberg B. S., Bove A. A., Idell S. Redistribution on the thallium scan in myocardial sarcoidosis: concise communication. J Nucl Med. 1981 May;22(5):428–432. [PubMed] [Google Scholar]
  10. Roberts W. C., McAllister H. A., Jr, Ferrans V. J. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med. 1977 Jul;63(1):86–108. doi: 10.1016/0002-9343(77)90121-8. [DOI] [PubMed] [Google Scholar]
  11. Silverman K. J., Hutchins G. M., Bulkley B. H. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978 Dec;58(6):1204–1211. doi: 10.1161/01.cir.58.6.1204. [DOI] [PubMed] [Google Scholar]
  12. Tachibana T., Ohmori F., Ueda E. Clinical study on cardiac sarcoidosis. Ann N Y Acad Sci. 1986;465:530–542. doi: 10.1111/j.1749-6632.1986.tb18530.x. [DOI] [PubMed] [Google Scholar]
  13. Tellier P., Valeyre D., Nitenberg A., Foult J. M., Bedig G., Battesti J. P. Cardiac sarcoidosis: reversion of myocardial perfusion abnormalities by dipyridamole. Eur J Nucl Med. 1985;11(6-7):201–204. doi: 10.1007/BF00279069. [DOI] [PubMed] [Google Scholar]
  14. Wasserman K. The anaerobic threshold measurement in exercise testing. Clin Chest Med. 1984 Mar;5(1):77–88. [PubMed] [Google Scholar]
  15. Wiens R. D., Lafia P., Marder C. M., Evans R. G., Kennedy H. L. Chronotropic incompetence in clinical exercise testing. Am J Cardiol. 1984 Jul 1;54(1):74–78. doi: 10.1016/0002-9149(84)90306-0. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES